Connect with us

Hi, what are you looking for?


GlaxoSmithKline Approves Sotrovimab Reportedly Effective Against Covid-19’s Omicron Variant

5 Cases of Omicron Variant Now Confirmed in New York
Image credits: (WTN/YouTube)

On Thursday, U.K. lawmakers just greenlit a drug from pharmaceutical giant GlaxoSmithKline (GSK) that is said to treat individuals who are deemed to have higher risks of catching Covid-19. The pharma firm even claims that the latest medication may well seem to be effective against the recently identified Omicron strain.  

Enter Sotrovimab  

Dubbed as sotrovimab, the new drug – according to the Medicines and Healthcare products Regulatory Agency (MHRA) – is an antibody treatment that is said to be safe and effective in the reduction of the risk of getting hospitalized and death in individuals having mild to moderate symptoms of Covid-19 who are at an elevated risk of progressing to a severe one, Medical Xpress reports 

Further, this new drug is a monoclonal antibody which is a type of protein that binds itself to the coronavirus’ spike protein. This results in the reduction of the virus’ activity to access the body cells.   

Alongside GSK, California-based Vir Biotechnology also took part in the development of sotrovimab.    

Sotrovimab against the Omicron variant  

In a statement by GSK, it was revealed within the drug’s preclinical data that it is retaining the activity against key mutations of the latest Omicron strain of the coronavirus.  

Additionally, the World Health Organization (WHO) stated that sotrovimab has shown continuous activity against the entirety of the tested variants of interest and concern.  

It was highlighted that there is still continuous testing to confirm sotrovimab’s neutralizing activity against all of the mutations of the Omicron variant as an update is scheduled to be rolled out by the end of the year.  

MHRA revealed that a dose of this new drug from GSK can reduce the risk of hospitalization and death by 79 percent among adults with symptomatic Covid-19 infection.  

Omicron case in the U.S.  

Chronicle News recently reported that Covid-19’s new Omicron variant has already entered the United States as this was detected from an individual in California who happens to have traveled from South Africa. According to National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci, the person is undergoing self-quarantine and is as of late experiencing mild symptoms as these are said to be improving. 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Us News

The Social Security beneficiaries are worried about the fate of payroll taxes in 2022. Several factors are involved in calculating these taxes, including wages,...

Personal Finance News

As per, more than 169 million stimulus checks were given out to approved Americans in the third round, and some are calling for...

Us News

Credit cards are convenient and yet they are not for everyone. If you are someone who misses payment deadlines, you should avoid credit cards...

Cryptocurrency News

Walmart is the latest big business house to enter the world of Cryptocurrency and NFT. The retailing giant is taking the first tentative steps...

Us News

When it comes to personal finance, the first thing that any expert will tell you is not to earn more, but to save more....

Us News

The US families have received half of the child tax credit payments in 2021; IRS will issue the remaining payments while the parents file...